Maiko Kakimoto

1.1k total citations
9 papers, 935 citations indexed

About

Maiko Kakimoto is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Maiko Kakimoto has authored 9 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Clinical Biochemistry and 3 papers in Physiology. Recurrent topics in Maiko Kakimoto's work include Nitric Oxide and Endothelin Effects (3 papers), Adenosine and Purinergic Signaling (2 papers) and Advanced Glycation End Products research (2 papers). Maiko Kakimoto is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Adenosine and Purinergic Signaling (2 papers) and Advanced Glycation End Products research (2 papers). Maiko Kakimoto collaborates with scholars based in Japan. Maiko Kakimoto's co-authors include Toyoshi Inoguchi, Hajime Nawata, Hideki Sumimoto, Noriyuki Sonoda, Kunihisa Kobayashi, Toshiyo Sonta, Takashi Etoh, Yu Hai, Minako Imamura and Hirotaka Tsubouchi and has published in prestigious journals such as Diabetes, Biochemical and Biophysical Research Communications and Journal of the American Society of Nephrology.

In The Last Decade

Maiko Kakimoto

8 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maiko Kakimoto Japan	8	357	294	285	183	141	9	935
Toshiyo Sonta Japan	11	345 1.0×	396 1.3×	263 0.9×	234 1.3×	120 0.9×	13	1.2k
Sih Min Tan Australia	17	547 1.5×	207 0.7×	316 1.1×	183 1.0×	152 1.1×	32	1.2k
Hirotaka Tsubouchi Japan	8	232 0.6×	269 0.9×	164 0.6×	208 1.1×	98 0.7×	9	827
Naotaka Sekiguchi Japan	10	250 0.7×	285 1.0×	164 0.6×	139 0.8×	91 0.6×	22	803
Josefa Pete Australia	7	329 0.9×	118 0.4×	351 1.2×	197 1.1×	111 0.8×	9	891
Tomoko Matsuo Japan	8	253 0.7×	132 0.4×	159 0.6×	130 0.7×	105 0.7×	8	671
Gautham Yepuri United States	11	292 0.8×	297 1.0×	130 0.5×	118 0.6×	177 1.3×	20	974
Naoichi Sato Japan	7	203 0.6×	198 0.7×	112 0.4×	114 0.6×	94 0.7×	11	625
Haijiang Wu China	18	612 1.7×	162 0.6×	126 0.4×	95 0.5×	114 0.8×	27	1.1k
C Sui China	3	281 0.8×	247 0.8×	119 0.4×	148 0.8×	135 1.0×	4	711

Countries citing papers authored by Maiko Kakimoto

Since Specialization

Citations

This map shows the geographic impact of Maiko Kakimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maiko Kakimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maiko Kakimoto more than expected).

Fields of papers citing papers by Maiko Kakimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maiko Kakimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maiko Kakimoto. The network helps show where Maiko Kakimoto may publish in the future.

Co-authorship network of co-authors of Maiko Kakimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Maiko Kakimoto. A scholar is included among the top collaborators of Maiko Kakimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maiko Kakimoto. Maiko Kakimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Asano, Takashi, et al.. (2024). Relationship between Early-onset Adverse Events and Drug Plasma Concentrations in Patients Receiving Oral Voriconazole. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 50(9). 494–503.

Tsubouchi, Hirotaka, Toyoshi Inoguchi, Maiko Kakimoto, et al.. (2004). Sulfonylurea as well as elevated glucose levels stimulate reactive oxygen species production in the pancreatic β-cell line, MIN6—a role of NAD(P)H oxidase in β-cells. Biochemical and Biophysical Research Communications. 326(1). 60–65. 40 indexed citations

Etoh, Tetsuji, Toyoshi Inoguchi, Maiko Kakimoto, et al.. (2003). Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia. 46(10). 1428–1437. 210 indexed citations

Inoguchi, Toyoshi, Toshiyo Sonta, Hirotaka Tsubouchi, et al.. (2003). Protein Kinase C–Dependent Increase in Reactive Oxygen Species (ROS) Production in Vascular Tissues of Diabetes. Journal of the American Society of Nephrology. 14(suppl_3). S227–S232. 355 indexed citations

Inoguchi, Toyoshi, Hirohito Tsubouchi, Tetsuji Etoh, et al.. (2003). A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase. Current Medicinal Chemistry. 10(17). 1759–1764. 34 indexed citations

Kakimoto, Maiko, Toyoshi Inoguchi, Toshiyo Sonta, et al.. (2002). Accumulation of 8-Hydroxy-2′-Deoxyguanosine and Mitochondrial DNA Deletion in Kidney of Diabetic Rats. Diabetes. 51(5). 1588–1595. 184 indexed citations

Inoguchi, Toyoshi, Yu Hai, Minako Imamura, et al.. (2001). Altered gap junction activity in cardiovascular tissues of diabetes. PubMed. 34(2). 86–91. 48 indexed citations

Hai, Yu, Toyoshi Inoguchi, Maiko Kakimoto, et al.. (2001). Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase c activity in cultured aortic smooth muscle cells. Diabetologia. 44(5). 614–620. 46 indexed citations

Inoguchi, Toyoshi, Fumio Umeda, Maiko Kakimoto, et al.. (2000). Chronic Sulfonylurea Treatment and Hyperglycemia Aggravate Disproportionately Elevated Plasma Proinsulin Levels in Patients with Type 2 Diabetes.. Endocrine Journal. 47(6). 763–770. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact